XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Cash flows from operating activities:          
Net loss     $ (4,128) $ (4,142)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Change in fair value of derivative liability $ (1,733) $ (1,223) (2,875) (2,444)  
Stock-based compensation expense     767 825  
Foreign exchange loss (gain)     428 (254)  
Depreciation expense     18 22  
Amortization expense 7 38 14 77  
Provision for (reversal of) inventory reserve     (15) 8  
Non-cash operating lease expense     20 25  
Changes in operating assets and liabilities:          
Accounts receivable     (8) (74)  
Other receivables     (19) 230  
Inventory     (349) 18  
Prepaid expense and other current assets     255 298  
Operating lease liabilities     (22) (26)  
Accounts payable     609 (53)  
Accrued and other current liabilities     (566) (426)  
Deferred revenue     (21) (14)  
Net cash used in operating activities     (5,892) (5,930)  
Cash flows from investing activities:          
Purchase of property and equipment     (5) (20)  
Net cash used in investing activities     (5) (20)  
Cash flows from financing activities:          
Proceeds from issuance of common stock     2,961    
Proceeds from issuance of warrants     4,829    
Proceeds from exercise of warrants     163    
Share issuance costs     (850)    
Net cash provided by financing activities     7,103    
Effect of currency exchange rate changes on cash and cash equivalents     (1)    
Net decrease in cash and cash equivalents     1,205 (5,950)  
Cash and cash equivalents at beginning of period     5,182 14,549 $ 8,599
Cash and cash equivalents at end of period $ 6,387 $ 8,599 6,387 $ 8,599 $ 6,387
Non-cash investing and financing transactions:          
Derivative warrant liability reclassified to equity on exercise of warrants     101    
Deferred offering costs reclassified to equity upon public offering     132    
Share issuance costs included in accounts payable     $ 150